KCM
ROIV icon

Kennedy Capital Management’s Roivant Sciences ROIV Stock Holding History

Kennedy Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.38M Buy
121,897
+10,002
+9% +$257K 0.07% 356
2025
Q4 		$2.43M Buy
111,895
+2,324
+2% +$45.9K 0.05% 402
2025
Q3 		$1.66M Buy
109,571
+53,869
+97% +$667K 0.04% 463
2025
Q2 		$628K Buy
55,702
+2,109
+4% +$22.9K 0.02% 535
2025
Q1 		$541K Buy
53,593
+685
+1% +$7.41K 0.01% 577
2024
Q4 		$626K Buy
52,908
+9,801
+23% +$116K 0.01% 628
2024
Q3 		$497K Buy
43,107
+6,194
+17% +$70.5K 0.01% 636
2024
Q2 		$390K Buy
36,913
+10,717
+41% +$117K 0.01% 650
2024
Q1 		$276K Buy
+26,196
New +$282K 0.01% 681

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.27B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return